Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins
- PMID: 1656366
Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins
Abstract
Wilms' tumor has been associated with deletions in two loci on chromosome 11, and the introduction of a translocated human chromosome [t(X;11)] into a Wilms' tumor cell line (G401.6TG.6) by microcell hybridization suppresses tumor formation in nude mice. The tumorigenic phenotype is restored in segregants of these microcell hybrids, in which the introduced chromosome is lost. We have used ultrahigh-resolution 'giant' two-dimensional gel electrophoresis of metabolically labeled cellular proteins and in vitro translation products of isolated mRNA to identify changes in cellular gene expression that occur in these cell lines. The changes in gene expression associated with these chromosomal manipulations per se are quite minimal. However, we have identified two proteins (p16 and p28) whose synthesis is consistently decreased in three non-tumorigenic (suppressed) microcell hybrid clones relative to parental and segregant tumorigenic lines. They are also decreased at the level of mRNA in at least two of the non-tumorigenic clones. The decrease of these proteins represents markers of the suppressed phenotype, and their down-regulation may conceivably mediate the suppression of tumorigenicity.
Similar articles
-
Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.J Cell Physiol. 1991 May;147(2):248-55. doi: 10.1002/jcp.1041470209. J Cell Physiol. 1991. PMID: 1645741
-
Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines.J Cell Biochem. 1990 Mar;42(3):135-42. doi: 10.1002/jcb.240420304. J Cell Biochem. 1990. PMID: 2318911
-
Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.Oncogene. 1990 Nov;5(11):1637-44. Oncogene. 1990. PMID: 2267132
-
Molecular and cellular biology of Wilms' tumour.Anticancer Res. 1989 Sep-Oct;9(5):1417-26. Anticancer Res. 1989. PMID: 2556071 Review.
-
Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.Semin Diagn Pathol. 1994 May;11(2):126-35. Semin Diagn Pathol. 1994. PMID: 7809506 Review.
Cited by
-
Characterization of a WiT49 cell line derived orthotopic model of Wilms tumor.Pediatr Blood Cancer. 2010 Feb;54(2):316-8. doi: 10.1002/pbc.22205. Pediatr Blood Cancer. 2010. PMID: 19824073 Free PMC article.
-
The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.Am J Pathol. 1993 Feb;142(2):375-80. Am J Pathol. 1993. PMID: 8382007 Free PMC article.
-
Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression.Nucleic Acids Res. 1996 Dec 1;24(23):4700-8. doi: 10.1093/nar/24.23.4700. Nucleic Acids Res. 1996. PMID: 8972856 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical